CI
IDXX icon

Corient IA’s Idexx Laboratories IDXX Stock Holding History

Corient IA’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419K Sell
745
-80
-10% -$51.3K 0.39% 87
2025
Q4 		$558K Hold
825
– – 0.53% 55
2025
Q3 		$527K Sell
825
-51
-6% -$31K 0.39% 86
2025
Q2 		$470K Hold
876
– – 0.28% 133
2025
Q1 		$368K Buy
+876
New +$380K 0.26% 161

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corient IA's IDXX Position: Q1 2026 in Review

Corient IA reduced its Idexx Laboratories (IDXX) stake by 9.7% in Q1 2026, selling an estimated $51.3K and leaving 745 shares worth $419K. The position accounts for 0.39% of the portfolio, ranked #87.

Corient IA first reported a position in IDXX in Q1 2025 and has held it in 5 quarters since. The position peaked at $558K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Corient IA held 745 shares of Idexx Laboratories worth $419K as of Q1 2026.
  • Corient IA sold 80 Idexx Laboratories shares in Q1 2026, an estimated $51.3K.
  • Idexx Laboratories made up 0.39% of Corient IA's portfolio in Q1 2026, its #87 holding.
  • Corient IA first reported a position in Idexx Laboratories in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Idexx Laboratories position peaked at $558K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.